Abel GA[au] - Search Results

Year	Number of Results
1999	1
2002	2
2004	1
2005	2
2006	1
2007	1
2008	5
2009	2
2010	3
2011	5
2012	13
2013	29
2014	24
2015	23
2016	30
2017	18
2018	24
2019	29
2020	18
2021	21
2022	10

1

Frailty and the management of hematologic malignancies.

Abel GA, Klepin HD. Abel GA, et al. Blood. 2018 Feb 1;131(5):515-524. doi: 10.1182/blood-2017-09-746420. Epub 2017 Nov 15. Blood. 2018. PMID: 29141942 Free article. Review.

2

Pentito.

Abel GA. Abel GA. JAMA Oncol. 2019 Apr 1;5(4):580. doi: 10.1001/jamaoncol.2018.6869. JAMA Oncol. 2019. PMID: 30763415 No abstract available.

3

Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study.

Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, Lyratzopoulos G. Koo MM, et al. Among authors: abel ga. Lancet Oncol. 2020 Jan;21(1):73-79. doi: 10.1016/S1470-2045(19)30595-9. Epub 2019 Nov 6. Lancet Oncol. 2020. PMID: 31704137 Free PMC article.

4

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN. Zhou Z, et al. Among authors: abel ga. Blood. 2014 Feb 6;123(6):837-42. doi: 10.1182/blood-2013-09-524108. Epub 2013 Nov 21. Blood. 2014. PMID: 24264230 Free PMC article.

5

Typical and atypical presenting symptoms of breast cancer and their associations with diagnostic intervals: Evidence from a national audit of cancer diagnosis.

Koo MM, von Wagner C, Abel GA, McPhail S, Rubin GP, Lyratzopoulos G. Koo MM, et al. Among authors: abel ga. Cancer Epidemiol. 2017 Jun;48:140-146. doi: 10.1016/j.canep.2017.04.010. Epub 2017 May 23. Cancer Epidemiol. 2017. PMID: 28549339 Free PMC article.

6

The Best Medicine.

Abel GA. Abel GA. JAMA Oncol. 2019 Mar 1;5(3):350. doi: 10.1001/jamaoncol.2018.6689. JAMA Oncol. 2019. PMID: 30703207 No abstract available.

7

Prevalence and Tolerance of Prognostic Uncertainty Among Thoracic Oncologists.

Habib AR, Chen R, Magnavita ES, Jaung T, Awad MM, Odejide O, Abel GA. Habib AR, et al. Among authors: abel ga. Oncologist. 2021 Aug;26(8):e1480-e1482. doi: 10.1002/onco.13788. Epub 2021 Apr 30. Oncologist. 2021. PMID: 33844365 Free PMC article.

8

Model solutions for ethical allocation during cancer medicine shortages.

Hantel A, Peppercorn J, Abel GA. Hantel A, et al. Among authors: abel ga. Lancet Haematol. 2021 Apr;8(4):e246-e248. doi: 10.1016/S2352-3026(21)00055-7. Lancet Haematol. 2021. PMID: 33770477 No abstract available.

9

Management of older adults with myelodysplastic syndromes (MDS).

Luskin MR, Abel GA. Luskin MR, et al. Among authors: abel ga. J Geriatr Oncol. 2018 Jul;9(4):302-307. doi: 10.1016/j.jgo.2017.12.002. Epub 2017 Dec 29. J Geriatr Oncol. 2018. PMID: 29290596 Review.

10

Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.

Abel GA, Klepin HD, Magnavita ES, Jaung T, Lu W, Shallis RM, Hantel A, Bahl NE, Dellinger-Johnson R, Winer ES, Zeidan AM. Abel GA, et al. Transfusion. 2021 Oct;61(10):2830-2836. doi: 10.1111/trf.16584. Epub 2021 Jul 12. Transfusion. 2021. PMID: 34251040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results